ENTPD1 and neoplasm: CD73 exerts its functions through various mechanisms in the tumor microenvironment, inhibiting the activation and effector function of T cells, inhibiting the killing effect of NK cells, and promoting immunosuppressor cells (MDSCs and Tregs) through CD39/CD73/A2AR pathway (31–33).